Ticker

Analyst Price Targets — EDAP

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
June 22, 2026 10:14 amLoop Capital Markets$10.00$4.76StreetInsider Lucid Capital Markets Starts EDAP TMS S.A. (EDAP) at Buy
April 9, 2026 1:16 pmSwayampakula RamakanthH.C. Wainwright$10.00$3.36TheFly EDAP TMS price target lowered to $10 from $14 at H.C. Wainwright
November 6, 2025 8:09 pmMichael SarconeJefferies$2.00$1.99StreetInsider EDAP TMS S.A. (EDAP) PT Raised to $2 at Jefferies
April 1, 2024 6:24 amSwayampakula RamakanthH.C. Wainwright$19.00$7.35TheFly EDAP TMS price target raised to $19 from $16 at H.C. Wainwright

Latest News for EDAP

Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion

Edap Tms NASDAQ: EDAP used its 2026 FocalTherics Investor Day to outline its shift toward becoming a “high-growth, pure-play robotic focal therapy company,” with management emphasizing the company's Focal One robotic high-intensity focused ultrasound, or HIFU, platform for prostate cancer and future indications.

MarketBeat • Jun 1, 2026
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy

, May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy Company will Begin Trading Under New Ticker Symbol "FOCL" at Market Open on June 1, 2026Company Intends to Report and Classify its Legacy Non-Core ESWL and Distribution Operating Segments as Discontinued Operations Beginning with Second Quarter 2026 Financial…

Globe News Wire • May 29, 2026
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer

, May 14, 2026 (GLOBE NEWSWIRE) -- AUSTIN, Texas – May 14, 2026 – EDAP TMS S.A. (Nasdaq: EDAP) today announced that it has entered into a letter of intent with Telix Pharmaceuticals Limited (“Telix”) to explore joint clinical research activities and physician education focused on the combination of EDAP's Focal One Robotic HIFU and Telix's PSMA PET imaging products in the management of prostate cancer.

GlobeNewsWire • May 14, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for EDAP.

No House trades found for EDAP.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top